Document is current
Any future updates will be listed below
-
Authors
Bhak, Youngjune https://orcid.org/0000-0002-9273-6984
Jeong, Hyoung-oh
Cho, Yun Sung
Jeon, Sungwon
Cho, Juok
Gim, Jeong-An
Jeon, Yeonsu https://orcid.org/0000-0003-4560-4142
Blazyte, Asta
Park, Seung Gu https://orcid.org/0000-0001-6464-5551
Kim, Hak-Min https://orcid.org/0000-0001-6066-2469
Shin, Eun-Seok https://orcid.org/0000-0002-9169-6968
Paik, Jong-Woo
Lee, Hae-Woo
Kang, Wooyoung
Kim, Aram
Kim, Yumi
Kim, Byung Chul
Ham, Byung-Joo
Bhak, Jong https://orcid.org/0000-0002-4228-1299
Lee, Semin https://orcid.org/0000-0002-9015-6046
-
Funding
Funding for this research was provided by:
Ministry of Science, ICT and Future Planning (NRF-016M3C4A7952635)
Ulsan National Institute of Science and Technology (2.160645.01, 1.190007.01, 1.190033.01)
- License Information
-
More Information
Article History
Received: 9 June 2019
Revised: 9 September 2019
Accepted: 24 September 2019
First Online: 17 October 2019
Conflict of interest
: H.J., Y.B., Y.S.C., B.C.K., J.B. and S.L. are listed as inventors on a patent application related to the work. Y.B., H.M.K., Y.S.C. and Y.K. are employees, E.S.S. is a chief medical officer, J.B. and B.C.K. are chief executive officers, and S.L. is on the scientific advisory board of Clinomics Inc. H.M.K., Y.S.C., J.B. and B.C.K. have an equity interest in the company. Those do not alter our adherence to Translational Pychiatry policies on sharing and materials
